These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 30391395)
41. Co-incidence of Turner syndrome and Duchenne muscular dystrophy - an important problem for the clinician. Kaczorowska E; Zimowski J; Cichoń-Kotek M; Mrozińska A; Purzycka J; Wierzba J; Limon J; Lipska-Ziętkiewicz BS Dev Period Med; 2016; 20(4):273-278. PubMed ID: 28216480 [TBL] [Abstract][Full Text] [Related]
42. [Report of four women with Duchenne or Becker muscular dystrophy]. Lescaut W; Butori C; Soriani MH; Desnuelles C Rev Med Interne; 2004 Jun; 25(6):464-7. PubMed ID: 15158318 [TBL] [Abstract][Full Text] [Related]
43. A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old. Nakagawa T; Takeuchi A; Kakiuchi R; Lee T; Yagi M; Awano H; Iijima K; Takeshima Y; Urade Y; Matsuo M Clin Chim Acta; 2013 Aug; 423():10-4. PubMed ID: 23603101 [TBL] [Abstract][Full Text] [Related]
44. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function. Sato Y; Yamauchi A; Urano M; Kondo E; Saito K Pediatr Neurol; 2014 Jan; 50(1):31-7. PubMed ID: 24138948 [TBL] [Abstract][Full Text] [Related]
45. Renal function in children and adolescents with Duchenne muscular dystrophy. Braat E; Hoste L; De Waele L; Gheysens O; Vermeersch P; Goffin K; Pottel H; Goemans N; Levtchenko E Neuromuscul Disord; 2015 May; 25(5):381-7. PubMed ID: 25683700 [TBL] [Abstract][Full Text] [Related]
48. Next Generation Sequencing approach to molecular diagnosis of Duchenne muscular dystrophy; identification of a novel mutation. Ebrahimzadeh-Vesal R; Teymoori A; Azimi-Nezhad M; Hosseini FS Gene; 2018 Feb; 644():1-3. PubMed ID: 29246534 [TBL] [Abstract][Full Text] [Related]
49. Early diagnosis of Duchenne muscular dystrophy is essential to improve long term outcomes. Quinlivan R Arch Dis Child; 2014 Dec; 99(12):1061. PubMed ID: 25395585 [No Abstract] [Full Text] [Related]
50. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy. Dubowitz V Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656 [No Abstract] [Full Text] [Related]
54. Reliability and validity analyses of the North Star Ambulatory Assessment in Brazilian Portuguese. Okama LO; Zampieri LM; Ramos CL; Toledo FO; Alves CRJ; Mattiello-Sverzut AC; Mayhew A; Sobreira CFR Neuromuscul Disord; 2017 Aug; 27(8):723-729. PubMed ID: 28648683 [TBL] [Abstract][Full Text] [Related]
55. [Neurodevelopmental disorders as the presenting symptom of Duchenne's muscular dystrophy]. Camacho-Salas A; Núñez-Enamorado N; Zamora B; Hernández-Laín A; Simón-De Las Heras R Rev Neurol; 2014 Feb; 58(4):187-8. PubMed ID: 24504883 [TBL] [Abstract][Full Text] [Related]
56. [Skin cells for use as an alternate diagnostic method for Duchenne muscular dystrophy]. Mornet D Med Sci (Paris); 2018 Nov; 34 Hors série n°2():42-43. PubMed ID: 30418146 [No Abstract] [Full Text] [Related]
57. Duchenne and Becker muscular dystrophies. Flanigan KM Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084 [TBL] [Abstract][Full Text] [Related]
59. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy. Thongsing A; Likasitwattanakul S; Sanmaneechai O Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775 [TBL] [Abstract][Full Text] [Related]
60. Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy. Leigh F; Ferlini A; Biggar D; Bushby K; Finkel R; Morgenroth LP; Wagner KR Pediatrics; 2018 Oct; 142(Suppl 2):S5-S16. PubMed ID: 30275245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]